Literature DB >> 25349199

A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.

Carolin E Sadowski1, Svjetlana Lovric1, Shazia Ashraf1, Werner L Pabst1, Heon Yung Gee1, Stefan Kohl1, Susanne Engelmann1, Virginia Vega-Warner2, Humphrey Fang1, Jan Halbritter1, Michael J Somers1, Weizhen Tan1, Shirlee Shril1, Inès Fessi1, Richard P Lifton3, Detlef Bockenhauer4, Sherif El-Desoky5, Jameela A Kari5, Martin Zenker6, Markus J Kemper7, Dominik Mueller8, Hanan M Fathy9, Neveen A Soliman10, Friedhelm Hildebrandt11.   

Abstract

Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  FSGS; SRNS; genetic disease; kidney failure; nephrosis; steroid-resistant nephrotic syndrome

Mesh:

Substances:

Year:  2014        PMID: 25349199      PMCID: PMC4446877          DOI: 10.1681/ASN.2014050489

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  41 in total

1.  Getting a foothold in nephrotic syndrome.

Authors:  S Somlo; P Mundel
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

2.  Management of steroid-responsive nephrotic syndrome.

Authors:  P Niaudet; M Broyer
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

Review 3.  Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life.

Authors:  Friedhelm Hildebrandt; Saskia F Heeringa
Journal:  Kidney Int       Date:  2009-04       Impact factor: 10.612

4.  Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome.

Authors:  Kálmán Tory; Dóra K Menyhárd; Stéphanie Woerner; Fabien Nevo; Olivier Gribouval; Andrea Kerti; Pál Stráner; Christelle Arrondel; Evelyne Huynh Cong; Tivadar Tulassay; Géraldine Mollet; András Perczel; Corinne Antignac
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

5.  Rapid detection of monogenic causes of childhood-onset steroid-resistant nephrotic syndrome.

Authors:  Svjetlana Lovric; Humphrey Fang; Virginia Vega-Warner; Carolin E Sadowski; Heon Yung Gee; Jan Halbritter; Shazia Ashraf; Pawaree Saisawat; Neveen A Soliman; Jameela A Kari; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

6.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

7.  Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis.

Authors:  H I Cheong; H W Han; H W Park; I S Ha; K S Han; H S Lee; S J Kim; Y Choi
Journal:  Nephrol Dial Transplant       Date:  2000-01       Impact factor: 5.992

8.  ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

Authors:  Heon Yung Gee; Pawaree Saisawat; Shazia Ashraf; Toby W Hurd; Virginia Vega-Warner; Humphrey Fang; Bodo B Beck; Olivier Gribouval; Weibin Zhou; Katrina A Diaz; Sivakumar Natarajan; Roger C Wiggins; Svjetlana Lovric; Gil Chernin; Dominik S Schoeb; Bugsu Ovunc; Yaacov Frishberg; Neveen A Soliman; Hanan M Fathy; Heike Goebel; Julia Hoefele; Lutz T Weber; Jeffrey W Innis; Christian Faul; Zhe Han; Joseph Washburn; Corinne Antignac; Shawn Levy; Edgar A Otto; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

9.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Authors:  Shazia Ashraf; Heon Yung Gee; Stephanie Woerner; Letian X Xie; Virginia Vega-Warner; Svjetlana Lovric; Humphrey Fang; Xuewen Song; Daniel C Cattran; Carmen Avila-Casado; Andrew D Paterson; Patrick Nitschké; Christine Bole-Feysot; Pierre Cochat; Julian Esteve-Rudd; Birgit Haberberger; Susan J Allen; Weibin Zhou; Rannar Airik; Edgar A Otto; Moumita Barua; Mohamed H Al-Hamed; Jameela A Kari; Jonathan Evans; Agnieszka Bierzynska; Moin A Saleem; Detlef Böckenhauer; Robert Kleta; Sherif El Desoky; Duygu O Hacihamdioglu; Faysal Gok; Joseph Washburn; Roger C Wiggins; Murim Choi; Richard P Lifton; Shawn Levy; Zhe Han; Leonardo Salviati; Holger Prokisch; David S Williams; Martin Pollak; Catherine F Clarke; York Pei; Corinne Antignac; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

Review 10.  NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum.

Authors:  Karim Bouchireb; Olivia Boyer; Olivier Gribouval; Fabien Nevo; Evelyne Huynh-Cong; Vincent Morinière; Raphaëlle Campait; Elisabet Ars; Damien Brackman; Jacques Dantal; Philippe Eckart; Maddalena Gigante; Beata S Lipska; Aurélia Liutkus; André Megarbane; Nabil Mohsin; Fatih Ozaltin; Moin A Saleem; Franz Schaefer; Kenza Soulami; Roser Torra; Nicolas Garcelon; Géraldine Mollet; Karin Dahan; Corinne Antignac
Journal:  Hum Mutat       Date:  2013-12-09       Impact factor: 4.878

View more
  251 in total

Review 1.  Nephrology research--the past, present and future.

Authors:  Jürgen Floege; Robert H Mak; Bruce A Molitoris; Giuseppe Remuzzi; Pierre Ronco
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

Review 2.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

3.  Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.

Authors:  Eujin Park; Hee Gyung Kang; Young Hun Choi; Kyoung Bun Lee; Kyung Chul Moon; Hyeon Joo Jeong; Michio Nagata; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

4.  COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans.

Authors:  Thomas M Kitzler; Ronen Schneider; Stefan Kohl; Caroline M Kolvenbach; Dervla M Connaughton; Rufeng Dai; Nina Mann; Makiko Nakayama; Amar J Majmundar; Chen-Han W Wu; Jameela A Kari; Sherif M El Desoky; Prabha Senguttuvan; Radovan Bogdanovic; Natasa Stajic; Zaheer Valivullah; Monkol Lek; Shrikant Mane; Richard P Lifton; Velibor Tasic; Shirlee Shril; Friedhelm Hildebrandt
Journal:  Hum Genet       Date:  2019-06-22       Impact factor: 4.132

Review 5.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

6.  Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.

Authors:  Agnes Trautmann; Sven Schnaidt; Beata S Lipska-Ziętkiewicz; Monica Bodria; Fatih Ozaltin; Francesco Emma; Ali Anarat; Anette Melk; Marta Azocar; Jun Oh; Bassam Saeed; Alaleh Gheisari; Salim Caliskan; Jutta Gellermann; Lina Maria Serna Higuita; Augustina Jankauskiene; Dorota Drozdz; Sevgi Mir; Ayse Balat; Maria Szczepanska; Dusan Paripovic; Alexandra Zurowska; Radovan Bogdanovic; Alev Yilmaz; Bruno Ranchin; Esra Baskin; Ozlem Erdogan; Giuseppe Remuzzi; Agnieszka Firszt-Adamczyk; Elzbieta Kuzma-Mroczkowska; Mieczyslaw Litwin; Luisa Murer; Marcin Tkaczyk; Helena Jardim; Anna Wasilewska; Nikoleta Printza; Kibriya Fidan; Eva Simkova; Halina Borzecka; Hagen Staude; Katharina Hees; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2017-05-31       Impact factor: 10.121

7.  Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract.

Authors:  Amelie T van der Ven; Dervla M Connaughton; Hadas Ityel; Nina Mann; Makiko Nakayama; Jing Chen; Asaf Vivante; Daw-Yang Hwang; Julian Schulz; Daniela A Braun; Johanna Magdalena Schmidt; David Schapiro; Ronen Schneider; Jillian K Warejko; Ankana Daga; Amar J Majmundar; Weizhen Tan; Tilman Jobst-Schwan; Tobias Hermle; Eugen Widmeier; Shazia Ashraf; Ali Amar; Charlotte A Hoogstraaten; Hannah Hugo; Thomas M Kitzler; Franziska Kause; Caroline M Kolvenbach; Rufeng Dai; Leslie Spaneas; Kassaundra Amann; Deborah R Stein; Michelle A Baum; Michael J G Somers; Nancy M Rodig; Michael A Ferguson; Avram Z Traum; Ghaleb H Daouk; Radovan Bogdanović; Natasa Stajić; Neveen A Soliman; Jameela A Kari; Sherif El Desoky; Hanan M Fathy; Danko Milosevic; Muna Al-Saffar; Hazem S Awad; Loai A Eid; Aravind Selvin; Prabha Senguttuvan; Simone Sanna-Cherchi; Heidi L Rehm; Daniel G MacArthur; Monkol Lek; Kristen M Laricchia; Michael W Wilson; Shrikant M Mane; Richard P Lifton; Richard S Lee; Stuart B Bauer; Weining Lu; Heiko M Reutter; Velibor Tasic; Shirlee Shril; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2018-08-24       Impact factor: 10.121

Review 8.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

Review 9.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

10.  Altered expression of Crb2 in podocytes expands a variation of CRB2 mutations in steroid-resistant nephrotic syndrome.

Authors:  Tomohiro Udagawa; Tohaku Jo; Takeshi Yanagihara; Akira Shimizu; Jun Mitsui; Shoji Tsuji; Shinichi Morishita; Reiko Onai; Kenichiro Miura; Shoichiro Kanda; Yuko Kajiho; Haruko Tsurumi; Akira Oka; Motoshi Hattori; Yutaka Harita
Journal:  Pediatr Nephrol       Date:  2016-12-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.